Tomassetti Paola, Campana Davide, Piscitelli Lydia, Mazzotta Elena, Brocchi Emilio, Pezzilli Raffaele, Corinaldesi Roberto
Department of Internal Medicine and Gastroenterology, University of Bologna, Policlinico S.Orsola-Malpighi, Via Massarenti, 9, 40138, Bologna, Italy.
World J Gastroenterol. 2005 Sep 21;11(35):5423-32. doi: 10.3748/wjg.v11.i35.5423.
In this article, we have reviewed the main therapeutic measures for the treatment of Zollinger-Ellison syndrome (ZES). Review of the literature was based on computer searches (Pub-Med, Index Medicus) and personal experiences. We have evaluated all the measures now available for treating patients with sporadic gastrinomas or gastrinomas associated with Multiple Endocrine Neoplasia Type 1, (MEN 1) including medical therapy such as antisecretory drugs and somatostatin analogs (SST), chemotherapy and chemoembolization, and surgical procedures. In ZES patients, the best therapeutic procedure is surgery which, if radical, can be curative. Medical treatment can be the best palliative therapy and should be used, when possible, in association with surgery, in a multimodal therapeutic approach.
在本文中,我们回顾了治疗卓-艾综合征(ZES)的主要治疗措施。文献回顾基于计算机检索(PubMed、医学索引)及个人经验。我们评估了目前可用于治疗散发性胃泌素瘤或与1型多发性内分泌肿瘤(MEN 1)相关的胃泌素瘤患者的所有措施,包括抗分泌药物和生长抑素类似物(SST)等药物治疗、化疗和化疗栓塞以及手术程序。在ZES患者中,最佳治疗方法是手术,如果是根治性手术,则可能治愈。药物治疗可以是最佳的姑息治疗方法,应尽可能与手术联合使用,采用多模式治疗方法。